HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao-Liang Wu Selected Research

WK175

7/2010A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao-Liang Wu Research Topics

Disease

46Neoplasms (Cancer)
03/2024 - 01/2003
13Urinary Bladder Neoplasms (Bladder Cancer)
09/2023 - 02/2006
13Inflammation (Inflammations)
03/2022 - 04/2005
11Experimental Arthritis
11/2022 - 01/2005
11Arthritis (Polyarthritis)
08/2022 - 04/2005
9Rheumatoid Arthritis
08/2022 - 01/2005
7Infections
01/2024 - 10/2006
7Hepatocellular Carcinoma (Hepatoma)
07/2017 - 01/2003
5Lung Neoplasms (Lung Cancer)
05/2022 - 05/2010
5Disease Progression
11/2019 - 01/2005
4Hypoxia (Hypoxemia)
09/2023 - 02/2005
4Neoplasm Metastasis (Metastasis)
05/2023 - 08/2008
4Human Influenza (Influenza)
02/2023 - 10/2011
4Non-alcoholic Fatty Liver Disease
01/2020 - 11/2013
4Osteoarthritis
10/2012 - 02/2009
3Idiopathic Pulmonary Fibrosis
02/2024 - 05/2021
3Tendinopathy (Tendonitis)
09/2022 - 01/2018
3Neuralgia (Stump Neuralgia)
08/2022 - 11/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 08/2012
3Ischemia
03/2022 - 07/2010
3Carcinogenesis
06/2019 - 07/2016
3Insulin Resistance
07/2016 - 11/2015
3Transitional Cell Carcinoma
10/2009 - 02/2006
2Colitis
04/2024 - 06/2023
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2024 - 01/2017
2Proteinuria
05/2023 - 01/2021
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2023 - 06/2021
2Lupus Nephritis
05/2023 - 12/2020
2Virus Diseases (Viral Diseases)
02/2023 - 10/2011
2Hypertension (High Blood Pressure)
01/2021 - 03/2014
2Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020 - 01/2020
2Hyperplasia
10/2016 - 02/2007
2Synovitis
10/2016 - 01/2005
2Chronic Obstructive Pulmonary Disease (COPD)
02/2016 - 01/2013
2Emphysema
02/2016 - 01/2013
2Carcinoma (Carcinomatosis)
11/2013 - 12/2005
2Colonic Neoplasms (Colon Cancer)
05/2012 - 09/2010
2Necrosis
06/2011 - 10/2006
2Cataract (Cataracts)
09/2006 - 06/2006

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2002
11CytokinesIBA
06/2023 - 01/2005
8Cisplatin (Platino)FDA LinkGeneric
03/2024 - 05/2005
7prothymosin alphaIBA
01/2017 - 05/2005
6Therapeutic UsesIBA
07/2017 - 01/2005
5kallistatinIBA
09/2015 - 04/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 12/2004
4Small Interfering RNA (siRNA)IBA
09/2023 - 02/2008
4Biomarkers (Surrogate Marker)IBA
08/2019 - 09/2010
43-hydroxyphenyltrimethylammoniumIBA
04/2019 - 01/2009
4Antineoplastic Agents (Antineoplastics)IBA
05/2009 - 12/2004
3Histones (Histone)IBA
05/2023 - 01/2013
3GoldIBA
05/2023 - 09/2007
3Long Noncoding RNAIBA
12/2022 - 12/2020
3ErbB Receptors (EGF Receptor)IBA
12/2022 - 12/2005
3MicroRNAs (MicroRNA)IBA
11/2022 - 10/2012
3Peptides (Polypeptides)IBA
03/2022 - 01/2017
3Fibrinogen (Factor I)FDA Link
01/2021 - 01/2016
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 06/2019
3Interleukin-17 (Interleukin 17)IBA
10/2016 - 02/2011
3Thrombospondin 1IBA
10/2010 - 01/2005
2Dextran SulfateIBA
04/2024 - 06/2023
2DNA (Deoxyribonucleic Acid)IBA
03/2024 - 01/2024
2Glycoproteins (Glycoprotein)IBA
02/2024 - 10/2011
2InterleukinsIBA
06/2023 - 09/2022
2Galectin 3 (LGALS3)IBA
05/2023 - 02/2023
2evodiamineIBA
03/2023 - 07/2017
2CaspasesIBA
03/2023 - 06/2011
2LuciferasesIBA
03/2022 - 01/2007
2Complementary DNA (cDNA)IBA
03/2022 - 10/2020
2Messenger RNA (mRNA)IBA
06/2021 - 01/2011
2nintedanibIBA
06/2021 - 05/2021
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2010
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 05/2017
2fullerenolIBA
01/2020 - 06/2019
2TensinsIBA
04/2019 - 05/2012
2Indicators and Reagents (Reagents)IBA
04/2019 - 11/2013
2Nuclear Localization Signals (Nuclear Localization Signal)IBA
04/2019 - 04/2007
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2019 - 05/2012
2Estrogen ReceptorsIBA
01/2018 - 07/2016
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 12/2015
2SmokeIBA
02/2016 - 01/2013
2Histone Deacetylases (Histone Deacetylase)IBA
02/2016 - 01/2013
2Insulin (Novolin)FDA Link
01/2016 - 11/2015
2Etoposide (VP 16)FDA LinkGeneric
11/2015 - 10/2006
2Toll-Like Receptor 4IBA
11/2015 - 01/2010
2LipidsIBA
10/2014 - 11/2013
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
06/2014 - 03/2011
2Transforming Growth Factor beta (TGF-beta)IBA
06/2013 - 01/2005
2Immunosuppressive Agents (Immunosuppressants)IBA
06/2013 - 03/2011
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2013 - 08/2008
2NF-kappa B (NF-kB)IBA
01/2013 - 01/2010
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2009 - 10/2006
2Flucytosine (Ancobon)FDA Link
01/2007 - 10/2006
2Cytosine DeaminaseIBA
01/2007 - 10/2006

Therapy/Procedure

15Therapeutics
09/2023 - 01/2003
4Drug Therapy (Chemotherapy)
12/2022 - 08/2012
2Intra-Articular Injections
01/2020 - 06/2019
2Traditional Medicine (Folk Remedies)
09/2014 - 03/2014
2Nephroureterectomy
10/2009 - 12/2005
2Aftercare (After-Treatment)
01/2007 - 02/2006